Visit the News Hub
COVID-19 Therapeutics Accelerator to fund international trial of chloroquine
Clare Ridley, MD, an assistant professor of anesthesiology at Washington University School of Medicine in St. Louis, works in the intensive care unit at Barnes-Jewish Hospital during the COVID-19 pandemic. Researchers at the university are helming a global study of an estimated 30,000 health-care workers to establish whether the antimalaria drug chloroquine might prevent or reduce the severity of COVID-19 infections in such workers.
With $9 million in philanthropic support, an international group of physicians and scientists is establishing a research network to evaluate promising therapies for COVID-19. The group, called the COVID-19 Research Outcomes Worldwide Network (CROWN) Collaborative, is testing whether the antimalaria drug chloroquine can prevent COVID-19 infection or decrease its severity in front-line health-care workers. An estimated 30,000 such workers from across the globe will participate in the clinical trial, which the collaborative is calling the CROWN CORONATION trial.
The collaborative and the trial are funded by the COVID-19 Therapeutics Accelerator, an initiative with contributions from an array of public and philanthropic donors, intended to support research and development to bring effective, accessible COVID-19 treatments to market as quickly as possible.
Washington University School of Medicine in St. Louis is the clinical coordinating center for this ambitious international trial. The investigators comprising the CROWN Collaborative are from prominent research organizations in African, European, North American and South American countries, including Cameroon, Canada, Ireland, Ghana, Peru, South Africa, Switzerland, the United Kingdom, the United States, and Zambia.
Because of their repeated close contacts with infected patients, front-line health-care workers in all parts of the world have a higher risk of contracting COVID-19 than most members of the general public, said one of the studys principal investigators, Michael S. Avidan, MD, the Dr. Seymour and Rose T. Brown Professor and head of the Department of Anesthesiology at Washington University. In some places, more than 10% of those who have become infected are health-care workers. There is an urgent need to identify drugs that are effective at preventing infection or mitigating its severity.
The study will recruit front-line health-care workers globally, including those from lower- and middle-income countries. Thats important because in many such countries there are relatively few health-care workers per capita, and protecting them from severe COVID-19 infection would provide a substantial public health benefit.
An important way to protect the public at large is to do our best to protect the health-care workers, Avidan said It is very important that there is a global effort to protect health-care workers because when it comes to COVID-19, were all in this together. Finding ways to keep health-care workers from getting seriously ill is one of the most important ways to protect vulnerable people everywhere.
This new trial will be important because of its immense size and global reach, as well as its use of three different but well-established chloroquine dose schedules in healthy people. Health-care workers in the trial will be divided randomly into four groups. Three of the groups will receive chloroquine at various doses. The fourth group will receive an inactive placebo. The researchers want to learn whether the drug can prevent health-care workers from developing COVID-19 disease or decrease the severity of illness for those who do become infected.
The researchers also want to determine the lowest dose required to provide a benefit. Health-care workers in the study will receive lower doses of chloroquine than have been given in most other trials that have focused on treating patients already sick with COVID-19. That is important because lower doses of chloroquine should have fewer side effects. Plus, with a limited supply of chloroquine globally, if a lower dose turns out to be just as effective as a higher dose, many more people could benefit from the drug.
When people have to travel to parts of the world where malaria is a problem, they often take low doses of chloroquine to help prevent infection, said Avidan, also a professor of psychiatry and of surgery. We want to learn whether this drug might work in a similar fashion in the case of COVID-19, or at the very least, whether low-dose chloroquine might help prevent the severe and life-threatening complications associated with the illness.
Charge nurse Caroline Becker adjusts her face shield before entering a patients room at Barnes-Jewish Hospital.
The study will last five months. Health-care workers who participate will take chloroquine or a placebo for the first three months and will be monitored for another two months. Those previously infected with COVID-19 or those who have underlying medical problems that might make it unsafe to take chloroquine, such as heart ailments, will not be eligible to participate.
Data from the trial sites will be compiled at University College London. Laurence Lovat, MD, PhD, a professor of gastroenterology and biophotonics, is the study leader in the United Kingdom.
Our hypothesis is that chloroquine may decrease the COVID-19 burden by decreasing entry of the novel coronavirus into host cells and by inhibiting viral replication, Lovat said. Furthermore, with its anti-inflammatory properties, chloroquine might dampen the exaggerated and unregulated immune response in the host, which often is responsible for the unpredictable and severe complications of COVID-19.
The CROWN CORONATION trials other principal investigators are Ramani Moonesinghe, MD, a professor of perioperative medicine at University College London, and Helen Rees, MD, executive director of the Wits Reproductive Health and HIV Institute in Johannesburg.
In the African region, the health-care workforce is under-resourced and overstretched, and the impact of the COVID-19 pandemic will make this situation worse, Rees said. If an inexpensive drug such as chloroquine could help protect our health workers, it would provide important insurance for many countries whose health-care systems could collapse if large numbers of health-care workers were to become infected and could not care for others who were sick with COVID-19.
The investigative team at Washington University includes Avidan, Mary Politi, PhD, a professor of surgery in the Division of Public Health Sciences; Erik Dubberke, MD, and Elvin Geng, MD, both professors of medicine in the Division of Infectious Diseases; and Graham Colditz, MD, DrPh, the Niess-Gain Professor of Surgery and director of the Division of Public Health Sciences; George Kyei, MD, PhD, an assistant professor of medicine in the Division of Infectious Diseases; Victor Davila-Roman, MD, a professor of medicine, of anesthesiology and of radiology and associate director of the Center for Global Health in the Institute for Public Health.
There is quite a bit of interest in chloroquine for both the prevention and treatment of COVID-19 infection, Avidan said. It has shown promise treating patients with COVID-19, but the only way to determine accurately whether this drug actually works is to conduct rigorous, large-scale, randomized trials in multiple locations.
Politi, a leader in health decision-making, said she is particularly enthusiastic about the design of the study.
The trial will be focused on health-care workers and their safety so that they can continue to care for patients around the world, she said. In addition to helping us study whether chloroquine works, and at what dose, all participants will receive education about COVID-19 and will be screened for evidence of infection. The trial has an adaptive design to learn from early study results. After a certain time period, if at least two of the chloroquine doses are demonstrating a benefit, we could stop assigning people to take placebo.
COVID-19 Therapeutics Accelerator donors include the Bill & Melinda Gates Foundation, Wellcome, Mastercard, U.K. Department for International Development, Chan Zuckerberg Initiative, Michael & Susan Dell Foundation, Avast, Zhang Yiming, Alwaleed Philanthropies, EQT and Madonna.
Washington University School of Medicines 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.
- A bill would spend $1 billion on diversifying medical schools to close the racial health gap - NBC News - August 10th, 2020
- Pandemic acts as dress rehearsal for new medical school curriculum - Washington University School of Medicine in St. Louis - August 10th, 2020
- The Unnamed Hero - Pager Publications, Inc. - August 10th, 2020
- Testing is the key to a successful fall reopening on campuses (opinion) - Inside Higher Ed - August 10th, 2020
- TUNE IN: Alexandria Addressing Back-to-School Worries in Virtual Town Hall - The Zebra - August 10th, 2020
- Community Healthcare honored during National Health Center Week - Times Record News - August 10th, 2020
- When Things Arent OK With a Childs Mental Health - The New York Times - August 10th, 2020
- Making sure patients, physicians know about the advances in treating female cancers - Norton Healthcare - August 10th, 2020
- 'We Are Here to Help Them' | Harvard Medical School - Harvard Medical School - August 10th, 2020
- In the face of challenges posed by a pandemic and racism, the White Coat Ceremony underscores the importance of our shared humanity - AAMC - August 10th, 2020
- Physician Group Wants Medical Schools To Waive The MCAT This Year - Physicians News Digest - August 10th, 2020
- Born with 1 hand, she's an inspiration in virus fight - ABC News - August 10th, 2020
- What to Expect in Medical School - AAMC for Students ... - August 8th, 2020
- International med students ease the path for others with new mentor group - STAT - August 8th, 2020
- Texas schools reopening mandate sets off another local control debate - The Texas Tribune - August 8th, 2020
- Amid COVID-19 Pandemic, Morehouse School of Medicine Welcomes Its... - Diverse: Issues in Higher Education - August 8th, 2020
- Guntersville native joins Andrews Sports med team | Free Share - Sand Mountain Reporter - August 8th, 2020
- COVID-19 changing study of medicine on Long Island - Newsday - August 8th, 2020
- Health Care Workers Of Color Nearly Twice As Likely As Whites To Get COVID-19 - WUSF News - August 8th, 2020
- Dancing Wildcats Enjoy Smoother Transition to the Field of Medicine - UKNow - August 8th, 2020
- Kindness is the best medicine - Argus Leader - August 8th, 2020
- Kindness is the best medicine | Coronavirus | rocketminer.com - Daily Rocket Miner - August 8th, 2020
- With academic health center, the imagined can be reality - Las Vegas Sun - August 8th, 2020
- Need to Take the MCAT? You'll Still Have to Do It in Person - The New York Times - August 8th, 2020
- Why isn't ventilation part of the conversation on reopening schools? - STAT - August 8th, 2020
- A UT undergrad helped build the app that will assist students coming back to school this fall. Here's what it can do. - UT News | The University of... - August 8th, 2020
- Med School Professor Removed from Fellowship Director Post, Apparently for Publishing Anti-Affirmative-Action Journal Article - Reason - August 7th, 2020
- Good Shepherd celebrates one of it's first graduates on track to realize dream of becoming doctor - WDSU New Orleans - August 7th, 2020
- Change the course of the pandemic: UMass Medical School, Boston tech company at center of national push to - MassLive.com - August 7th, 2020
- Duality Health Begins Rapid Blockchain Innovation Cycle with Health Product Innovation Team at Dell Medical School - Tyler Morning Telegraph - August 7th, 2020
- Deciding whether to send your child back to school? Heres what the experts say to consider - nj.com - August 7th, 2020
- Kaine introduces bill that would support medical schools in underserved areas - WDVM 25 - August 4th, 2020
- Medical school affiliates on lack of diversity, burden of the 'minority tax' - The Stanford Daily - August 4th, 2020
- International medical school graduates need an easier path to practice in the US | TheHill - The Hill - August 4th, 2020
- The 'dura mater' handles medical training and motherhood with aplomb - DePauw University - August 4th, 2020
- Emory University doctor and former teacher suggests staggered starts, plexiglass lunch barriers to avoid COVID-19 spread in schools - 11Alive.com WXIA - August 4th, 2020
- President Houshmand and CMSRU Dean Reboli named to South Jersey BIZ Power 50 list - Rowan Today - August 4th, 2020
- 'Its a good mix of medicine and social justice': Medical student gets experience at NATIVE Project during pandemic - The Spokesman-Review - August 4th, 2020
- Addressing inequalities in women's health research | Contemporary OB/GYN - Contemporary Obgyn - August 4th, 2020
- New medical residents experience a different kind of welcome into URMC - University of Rochester - August 4th, 2020
- 'Not surprising': International graduate students respond to short-lived ICE directive - The Stanford Daily - August 4th, 2020
- MASKED-COVID Study to Assess Renal-Related Complications of COVID-19 - DocWire News - August 4th, 2020
- Addressing inequalities in women's health research - Contemporary Obgyn - August 4th, 2020
- Seeing the Health Care Profession Through the Eyes of a Medical Scribe - Hamilton College News - August 4th, 2020
- University of Medicine and Health Sciences Launches State-of-the-Art Virtual Tour - PR Web - August 4th, 2020
- Researchers With Game - Ohio Wesleyan University - August 4th, 2020
- List of medical schools in the United States - Wikipedia - August 3rd, 2020
- Disc Medicine Expands Leadership Team with Industry Veterans to Advance Hepcidin Modulating Therapies Toward the Clinic - PRNewswire - August 3rd, 2020
- Solomon Rajput '14 takes on Michigan incumbent for seat in Congress - The Dartmouth - August 3rd, 2020
- Fighting the Coronavirus, from New York to Utah - The New Yorker - August 3rd, 2020
- Boston doctor named hospital hero relied on human connection to get through COVID peak - Boston Herald - August 3rd, 2020
- Starkman: Beaumont Executive Paid $932000 by Hospital Vendor Whose Implants Were Pushed on Surgeons - Deadline Detroit - August 3rd, 2020
- Students need to be tested every 2-3 days for colleges to safely reopen - Yale News - August 3rd, 2020
- Taking Medicine and Tech to the Next Level: Ranney on New Brown-Lifespan Center for Digital Health - GoLocalProv - August 3rd, 2020
- Medical Schools Have Historically Been Wrong on Race - The New York Times - August 3rd, 2020
- After the Match: The Match in the Age of COVID-19 : Emergency Medicine News - LWW Journals - July 31st, 2020
- North Philly coronavirus risk: Temple University's return to campus is irresponsible - On top of Philly news - Billy Penn - July 31st, 2020
- Researchers Discover Stem Cells in Optic Nerve that Preserve Vision - Newswise - July 31st, 2020
- Pre-med students spend the summer studying COVID-19 - DePauw University - July 31st, 2020
- The Author of Blacks in Medicine on Race, Racism, and Health Outcomes - KCET - July 31st, 2020
- Five Questions With: Dr. Ben Abo on Snakes and Television - EMSWorld - July 31st, 2020
- We asked 20 medical experts whether they're sending their own kids back to school. Here's what they had to say - CNBC - July 31st, 2020
- NYU Long Island School of Medicine Is First School on Long Island to Start 202021 Term, May Be Microcosm of 'Hybrid' Class Model - NYU Langone Health - July 31st, 2020
- Medical education in the time of COVID-19 - Science Advances - July 31st, 2020
- Rutgers New Jersey Medical School - July 31st, 2020
- Discrimination in the medical curriculum: are medical schools providing students with equal access to the medical profession? - The European Sting - July 31st, 2020
- Marshall School of Medicine 1 of 9 schools to offer Mission Act scholarships to veterans - Huntington Herald Dispatch - July 30th, 2020
- Irish medical school students learning about Sarnia area - Sarnia and Lambton County This Week - July 30th, 2020
- Michigan Medicine named one of best 20 hospitals in U.S. News rankings - MLive.com - July 30th, 2020
- What Cuba Can Teach the U.S. About Confronting the COVID-19 Pandemic - southseattleemerald.com - July 30th, 2020
- Stem Cell Therapy Injuries More Widespread Than We Knew - UConn Today - July 30th, 2020
- Want to be a doctor? A lawyer? COVID-19 cases are rising, but these high-stakes exams are in-person only - USA TODAY - July 29th, 2020
- Payne named associate dean for health information and data science Washington University School of Medicine in St. Louis - Washington University... - July 29th, 2020
- Mind the Gap: A 20-Year-Old Black Medical Student Is Writing a Guide Illustrating How Common Medical Symptom - The Root - July 29th, 2020
- Elizabeth Williams Talks Healthcare With Her Series "E Talks With Docs" - Jul 28, 2020 - Sports Are From Venus - July 29th, 2020
- School of Medicine one of nine schools to offer Mission Act scholarships to veterans - HNN Huntingtonnews.net - July 29th, 2020
- News | From ESL to Medical School, RIC Grad Overcomes Obstacles in Pursuit of Her Dreams - Rhode Island College News - July 29th, 2020
- Med students make history in Clovis - The Business Journal - July 29th, 2020
- The Doctor Behind the Disputed Covid Data - The New York Times - July 29th, 2020
- Dr. Stella Immanuel: 5 Fast Facts You Need to Know - Heavy.com - July 29th, 2020